scholarly journals Aerobic Exercise Effects on Quality of Life and Psychological Distress After an Implantable Cardioverter Defibrillator

2020 ◽  
Vol 40 (2) ◽  
pp. 94-101 ◽  
Author(s):  
Cynthia M. Dougherty ◽  
Robert L. Burr ◽  
Peter J. Kudenchuk ◽  
Robb W. Glenny
2002 ◽  
Vol 1 (3) ◽  
pp. 213-219 ◽  
Author(s):  
Diane L Carroll ◽  
Glenys A Hamilton ◽  
Barbara J Kenney

Background: Living with an implantable cardioverter defibrillator (ICD) has positive health benefits but the impact on well-being and quality of life over a period of time has not been studied in depth. Aim: To follow patients prospectively over the first year and to compare the changes from time of ICD implantation, to 6 months and 1 year. Methods: Generalized linear models were used to assess changes through examination of health status (SF-36), psychological distress (POMS), and quality of life (QLI) scores. Results: There were 19 females (27%) and 51 males (73%) in the sample with a mean age of 64 years. There were significant improvements over time in 3 of the 8 sub-concepts of health status: role physical ( P<0.001), vitality ( P<0.013) and social functioning ( P<0.001). The Profile of Mood States revealed significantly less total psychological distress at 6 months with a non-significant leveling off or increase at 1 year. The quality of life index revealed no significant changes over time. Conclusions: The effects of living with an ICD are not well understood. Research should continue to identify the impact over time in this population and sub-groups so that health care providers can address the social and psychological needs of this population.


EP Europace ◽  
2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii379-iii379
Author(s):  
Y. Kondo ◽  
S. Sasaki ◽  
S. Sears ◽  
M. Okamoto ◽  
B. Gerritse ◽  
...  

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P5132-P5132
Author(s):  
Y. Ohtsuki ◽  
T. Tomita ◽  
A. Kitano ◽  
H. Mochizuki ◽  
K. Yoshie ◽  
...  

Author(s):  
Margaret L. Campbell ◽  
Linda M. Gorman

Withdrawal of mechanical ventilation (MV), discontinuation of dialysis, and deactivation of cardiac devices are procedures that occur with relative frequency. The benefits of these therapies, when initiated, are to replace failing organs, extend life, and improve quality of life by relieving symptom distress associated with organ failure. When the burdens exceed the benefits, or when the patient is near death or unresponsive, decisions may be made to cease these therapies. In some cases, such as implantable cardioverter defibrillator (ICD) deactivation, no distress is anticipated. In others, such as discontinuing dialysis or withdrawing MV, measures to palliate anticipated distress must be applied. A peaceful death after cessation of life-prolonging therapies can be provided.


Sign in / Sign up

Export Citation Format

Share Document